Bottom line: MRNY seeks high weekly income by writing calls (and related strategies) against synthetic exposure to Moderna (MRNA). Biotech volatility can generate substantial option premiums, giving income investors a way to monetize MRNA’s price swings while collecting frequent distributions.
It is not a pure Moderna equity holding or a low-risk income product. Upside is capped, downside remains largely unprotected, and NAV can erode when distributions include significant return of capital or when the stock trends strongly. Concentration and biotech-sector risks are high.
Position size should reflect the high idiosyncratic volatility of a single biotech name. Always review the latest prospectus, distribution composition, and Moderna’s clinical/commercial outlook. This is not investment advice.
Distribution History for MRNY
| Month | Distributions | No. of shares | Net Distribution / share |
|---|---|---|---|
| October 2026 | $10.49 | 13 | $0.8069 |
| September 2026 | $32.28 | 52 | $0.6208 |
| August 2026 | $20.07 | 52 | $0.3860 |
| July 2026 | $21.79 | 65 | $0.3352 |
| June 2026 | $12.92 | 52 | $0.2485 |
| May 2026 | $10.34 | 52 | $0.1988 |
| April 2026 | $13.75 | 52 | $0.2644 |
| March 2026 | $18.55 | 52 | $0.3567 |
| February 2026 | $17.02 | 52 | $0.3273 |
| January 2026 | $18.68 | 65 | $0.2874 |
| December 2025 | $14.01 | 182 | $0.0770 |
| November 2025 | $9.02 | 372 | $0.0242 |
| Grand Total: | $1,076.52 | 3,753 | $0.2868 |
ETF Investment Summary
| Investment | Shares | Distributions | Purchase price / share | Real price / share | Market price / share |
|---|---|---|---|---|---|
| $1,563.12 | 13 | $1,076.52 | $20.30 | $120.24 | $39.67 |
Notes:
• Investment = Current Adjusted Cost Basis (after accounting for sells and distributions)
• Purchase price / share = Historical average price of all shares ever bought
• Real price / share = Current adjusted cost basis per remaining share (after distributions reduce basis)
• Market price / share = Latest market price of the ETF
Personal Chart – Real Price vs Real Price + Cumulative Distributions
Blue line = Real Price per share (cost basis after buys, sells & distributions)
Red line = Real Price + Cumulative Net Distributions received so far
Purple line = Cumulative Realised Capital Gains from sales
Green bars = Number of shares held at month-end
When the green bars drop to zero, the blue/red lines also go to zero (full exit of the position).